Share
Journal Information
Issue
Vol. 12. Issue 5.Pages 710-844 (September - October 2013)
Hepatology highlights
We are all trying to predict what we don’t know!
Kevork M. Peltekian
Ann Hepatol. 2013;12:710-2
Open access
Concise review
Coagulation abnormalities in the cirrhotic patient
Jimena Muciño-Bermejo, Raúl Carrillo-Esper, Misael Uribe, Nahum Méndez-Sánchez
Ann Hepatol. 2013;12:713-24
Open access
Original article
Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acid
Adriana Sánchez-García, Clara Patricia Ríos-Ibarra, Ana Rosa Rincón-Sánchez, Rocío Ortiz-López, Aurora Garza-Juárez, Jesús Morlett-Chávez, Herminia Martínez-Rodríguez, Ana María Rivas-Estilla
Ann Hepatol. 2013;12:725-32
Open access
The X-ray repair cross complementing protein 1 (XRCC1) rs25487 polymorphism and susceptibility to cirrhosis in Brazilian patients with chronic viral hepatitis
Samantha Therezinha Almeida Pereira Leite, Nathália Marques-Guimarães, Júlio César Silva-Oliveira, Francisco José Dutra-Souto, Raquel Alves-dos-Santos, Carmen Lucia Bassi-Branco
Ann Hepatol. 2013;12:733-9
Open access
Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients
Valentina Li Vecchi, Lydia Giannitrapani, Paola Di Carlo, Giovanni Mazzola, Pietro Colletti, Emanuele La Spada, Giovanni Vizzini, Giuseppe Montalto, Maurizio Soresi
Ann Hepatol. 2013;12:740-8
Open access
Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index
Stergios A. Polyzos, Jannis Kountouras, Athanasios Papatheodorou, Evangelia Katsiki, Kalliopi Patsiaoura, Efthimia Zafeiriadou, Christos Zavos, Evridiki Papadopoulou, Evangelos Terpos
Ann Hepatol. 2013;12:749-57
Open access
Primary care practitioners survey of non-alcoholic fatty liver disease
Adnan Said, Veronika Gagovic, Kristen Malecki, Marjory L. Givens, F. Javier Nieto
Ann Hepatol. 2013;12:758-65
Open access
Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients
Ron C. Gaba, Eric R. Kallwitz, Ahmad Parvinian, James T. Bui, Natasha M. Von Roenn, Jamie L. Berkes, Scott J. Cotler
Ann Hepatol. 2013;12:766-73
Open access
Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patients
Abdel-Rahman Zekri, Mohamed El-Kassas, Yasmin Saad, Abeer Bahnassy, Hany Khatab Sameh Seif El-Din, Samar K. Darweesh, Hanan Abdel Hafez, Gamal Esmat
Ann Hepatol. 2013;12:774-81
Open access
Treatment of polycystic liver disease: a hypothesis, patient characteristics, short and long-term results
Zheng Long-Xian, Liu Ai-Wu, Qin Hua-Dong, Cui Jun, Jiang Hui-Jie, Jia Hong-Bo
Ann Hepatol. 2013;12:782-90
Open access
Acute liver failure in under two year-olds - are there markers of metabolic disease on admission?
Ana Brett, Carla Pinto, Leonor Carvalho, Paula Garcia, Luísa Diogo, Isabel Gonçalves
Ann Hepatol. 2013;12:791-6
Open access
Within-patient temporal variance in MELD score and impact on survival prediction after TIPS creation
Ron C. Gaba, Kruti D. Shah, Patrick M. Couture, Ahmad Parvinian, Jeet Minocha, M. Grace Knuttinen, James T. Bui
Ann Hepatol. 2013;12:797-802
Open access
Oral Acetyl-L-Carnitine treatment in hepatic encephalopathy: view of evidence-based medicine
Qian Jiang, Gang Jiang, Ke-qing Shi, Hong Cai, Yi-xin Wang, Ming-hua Zheng
Ann Hepatol. 2013;12:803-9
Open access
Aspartate aminotransferase-to-platelet ratio index (APRI) for the non-invasive prediction of esophageal varices
Ângelo Zambam de Mattos, Angelo Alves de Mattos, Larissa Faraco Daros, Maiara Isabel Musskopf
Ann Hepatol. 2013;12:810-4
Open access
Notch signal protects non-parenchymal cells from ischemia/reperfusion injury in vitro by repressing ROS
Heng-Chao Yu, Lu Bai, Shu-Qiang Yue, De-Sheng Wang, Lin Wang, Hua Han, Ke-Feng Dou
Ann Hepatol. 2013;12:815-21
Open access
Images in hepatology
A giant calcified hepatic mass
Marco Biolato, Luca Miele, Carmine Di Stasi, Antonio Grieco
Ann Hepatol. 2013;12:822-3
Open access
Case report
Hepatocellular carcinoma that arose from primary Sjögren’s syndrome
Ming-Xian Yan, Jing Yang, Qing Sun, Chang-Hong Liu, Yi-Guo Wang, Wen-Qi Wang
Ann Hepatol. 2013;12:824-9
Open access
Rhombencephalitis by Listeria monocytogenes in a cirrhotic patient: a case report and literature review
Raúl Carrillo-Esper, Luis Daniel Carrillo-Cordova, Isis Espinoza de los Monteros-Estrada, Agustín Omar Rosales-Gutiérrez, Misael Uribe, Nahum Méndez-Sánchez
Ann Hepatol. 2013;12:830-3
Open access
Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration
Christoph Jüngst, Jens Krämer, Günther Schneider, Frank Lammert, Vincent Zimmer
Ann Hepatol. 2013;12:834-6
Open access
Letter to editor
Syncope during boceprevir treatment in hepatitis C
Ezequiel Ridruejo, Marcelo O. Silva, Oscar G. Mandó
Ann Hepatol. 2013;12:837-8
Open access
Liver news elsewhere
Liver stiffness measurements increase after meal ingestion - an important step towards standardization
Emmanuel A. Tsochatzis, Andrew K. Burroughs
Ann Hepatol. 2013;12:839-40
Open access
Instructions to authors
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
